Blood Cancers | Tumor

Breaking Down the Implications of Calquence Combination Therapy in MCL

February 13th 2025, 2:00pm

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma.

Bold Goal, Bold Action

February 4th 2025, 9:27pm

Article

As we observe World Cancer Day, I’m reflecting on my own family’s experience with blood cancer.

Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia

January 30th 2025, 10:00pm

Article

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission following second-line salvage therapy.

Life After MDS and Accomplishing Your Goals

January 28th 2025, 6:00pm

Article

After a long and difficult journey, I finally published the book I set out to write as my legacy, overcoming cancer and the challenges of deafness.

Whitesnake Guitarist John Sykes Died of Cancer, Mike Peters Starting CAR-T

January 24th 2025, 4:00pm

Article

From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s this week’s cancer news.

Putting an Emphasis on Patient Collaboration in MPN Treatment

January 6th 2025, 2:00pm

Video

Dr. Richard “Rick" Winneker discussed advice that he would provide to patients faced with a myeloproliferative neoplasm diagnosis.

FDA Grants Fast Track Designation to NX-5948 for R/R WM

December 30th 2024, 2:00pm

Article

NX-5948 has received fast track designation for adults with relapsed or refractory Waldenström macroglobulinemia who received at least two prior lines of therapy.